Investment Projects

Production and sales of medical test systems

Currently, the Initiator has built a workshop building with the necessary infrastructure.

Indicator Results
Investment amount, thousand US dollars 1 060
NPV of the Project thousand, US dollars 2 964
IRR, % 27,7%
EBITDA yield, % 19%
Payback period, years 6,1
Discounted payback period, years - - 7,4

Personalized medicine scientific research institute

All volume of services is planned to be realized in the domestic market of Kazakhstan.

Indicator Results
Investment amount, thousand US dollars 3 778
NPV of the Project thousand, US dollars 2 053
IRR, % 40,0%
EBITDA yield, %
Payback period, years 4,03
Discounted payback period, years - - 5,92

Dental implant and protector production

The Initiator is planning for 44% of product to be sold domestically in Kazakhstan, with the remainder exported to Central Asian countries such as Uzbekistan, Kyrgyzstan, Tajikistan and Turkmenistan.

Indicator Results
Investment amount, thousand US dollars 2 200
NPV of the Project thousand, US dollars 1 400
IRR, % 22,4%
EBITDA yield, %
Payback period, years 5,1
Discounted payback period, years - - 7,6

Simulation center of high medical technologies in the Turkestan region

This investment project plans to build and operate a simulation center for high medical technologies in the city of Turkestan.

Indicator Results
Investment amount, thousand US dollars 30 945
NPV of the Project thousand, US dollars 7 708
IRR, % 23,5%;
EBITDA yield, %
Payback period, years 6,3
Discounted payback period, years - - 11,1

Production of medical preparations

This investment project provides for the construction of a full-cycle pharmaceutical plant for the production of medicines.

Indicator Results
Investment amount, thousand US dollars 95
NPV of the Project thousand, US dollars 26,5
IRR, % 25,6%
EBITDA yield, % 53%
Payback period, years 7,68
Discounted payback period, years - - 12,96

Production of medical equipment

Finished products are planned to be sold in the domestic and foreign markets (Kyrgyzstan and Uzbekistan).

Indicator Results
Investment amount, thousand US dollars 33 296
NPV of the Project thousand, US dollars 36 373
IRR, % 41,5%
EBITDA yield, %
Payback period, years 6,7
Discounted payback period, years - -

Development and production of human vaccines according to GMP standards

This investment project ("Project") plans to build a plant for the development and production of vaccines and immunoglobulins for humans in accordance with GMP (Good Manufacturing Practice) standards.

Indicator Results
Investment amount, thousand US dollars 4 728
NPV of the Project thousand, US dollars 36 602
IRR, % 53
EBITDA yield, %
Payback period, years 3,4
Discounted payback period, years - -

Expansion of the existing production for the production of medicines, as well as endoprostheses of the hip and knee joint

This investment project (“Project”) plans to modernize the existing production of medicines and expand production through the production of hip endoprostheses and knee prostheses.

Indicator Results
Investment amount, thousand US dollars 18 137
NPV of the Project thousand, US dollars 19 944
IRR, % 40,9
EBITDA yield, %
Payback period, years 2,82
Discounted payback period, years - -

Modernization and expansion of the network of nephrocenters

Within the framework of the Project, it is planned to modernize existing medical centers in the cities of the Republic of Kazakhstan, as well as expand the network of nephrocenters.

Indicator Results
Investment amount, thousand US dollars 5117
NPV of the Project thousand, US dollars 34076
IRR, % 58,6
EBITDA yield, %
Payback period, years 3,6
Discounted payback period, years - -

Production of nonwovens

The Project involves the construction of a plant for the production of nonwovens with a capacity of 10,000 tons annually.

Indicator Results
Investment amount, thousand US dollars 43 591
NPV of the Project thousand, US dollars 18 272
IRR, % 19,0%
EBITDA yield, %
Payback period, years 7,6
Discounted payback period, years - -